# A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

> **NCT07239947** · PHASE1 · RECRUITING · sponsor: **Bambusa Therapeutics** · enrollment: 63 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** BBT001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07239947
- **Lead sponsor:** Bambusa Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-09
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-03-26
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239947, "A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07239947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*